• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Pepper Bio

Monday, June 03, 2024
CP
Oncology
Pepper Bio, the world's first transomics drug discovery company, leverages its proprietary database and analytics to identify promising first-in-class therapies, rediscover new uses for existing therapeutics, and rescue drugs in development on a path toward failure. By deciphering the root causes of diseases to identify effective treatments, Pepper Bio illuminates the fastest, safest path to drug discovery. Its AI-driven platform, COMPASS, is built on the world's first and largest proprietary transomics database, integrating genomic, transcriptomic, proteomic, and phosphoproteomic data. This holistic approach offers a full-picture understanding of biological systems—like driving using all your mirrors to know the impact of where other cars are on the road. Unlike other companies that focus on measuring gene and protein expression levels, Pepper Bio not only identifies what's present in a disease but also understands the activities and reasons behind these occurrences.
Pepper Bio
Company Website: https://pepper.bio/
Lead Product in Development: Pepper’s transomic bioplatform, COMPASS, integrates genomic, transcriptomic, proteomic, and phosphoproteomic data to help researchers repeatedly and predictably discover drugs to treat untreatable diseases.

Company HQ City

Dedham

Company HQ State

MA

Company HQ Country

United States

CEO/Top Company Official

Jon Hu

Development Phase of Primary Product

Discovery
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS